These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1384528)
1. Delineation of tissue damage mechanisms in experimental autoimmune encephalomyelitis (EAE). II. Characteristics of astrocyte detachment mediated by myelin basic protein (MBP) specific CD4+ T lymphocytes. Halachmi E; Pinkus R; Miron S; Ben-Nun A; Werkele H; Berke G J Autoimmun; 1992 Aug; 5(4):427-41. PubMed ID: 1384528 [TBL] [Abstract][Full Text] [Related]
2. Delineation of tissue damage mechanisms in experimental autoimmune encephalomyelitis (EAE). I. Cell detachment and lysis induced by encephalitogenic CD4+ T lymphocytes. Halachmi E; Ben-Nun A; Lehmann D; Karussis D; Wekerle H; Berke G J Autoimmun; 1992 Aug; 5(4):411-25. PubMed ID: 1384527 [TBL] [Abstract][Full Text] [Related]
3. Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties. Beraud E; Balzano C; Zamora AJ; Varriale S; Bernard D; Ben-Nun A J Neuroimmunol; 1993 Aug; 47(1):41-53. PubMed ID: 7690770 [TBL] [Abstract][Full Text] [Related]
4. Astrocytes induce hyporesponses of myelin basic protein-reactive T and B cell function. Xiao BG; Diab A; Zhu J; van der Meide P; Link H J Neuroimmunol; 1998 Aug; 89(1-2):113-21. PubMed ID: 9726833 [TBL] [Abstract][Full Text] [Related]
5. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. Myers KJ; Sprent J; Dougherty JP; Ron Y J Neuroimmunol; 1992 Nov; 41(1):1-8. PubMed ID: 1281165 [TBL] [Abstract][Full Text] [Related]
6. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Sun D; Wekerle H Nature; 1986 Mar 6-12; 320(6057):70-2. PubMed ID: 2419764 [TBL] [Abstract][Full Text] [Related]
7. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. Kojima K; Berger T; Lassmann H; Hinze-Selch D; Zhang Y; Gehrmann J; Reske K; Wekerle H; Linington C J Exp Med; 1994 Sep; 180(3):817-29. PubMed ID: 7520474 [TBL] [Abstract][Full Text] [Related]
8. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Dittel BN Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465 [TBL] [Abstract][Full Text] [Related]
9. Relative susceptibility of SJL/J and B10.S mice to experimental allergic encephalomyelitis is correlated with high and low responsiveness to myelin basic protein. Binder TA; Clark RB; Goldschneider I J Neuroimmunol; 1991 Dec; 35(1-3):31-43. PubMed ID: 1720137 [TBL] [Abstract][Full Text] [Related]
10. T cell responses to myelin basic protein in experimental autoimmune encephalomyelitis-resistant BALB/c mice. Abromson-Leeman S; Hayashi M; Martin C; Sobel R; al-Sabbagh A; Weiner H; Dorf ME J Neuroimmunol; 1993 Jun; 45(1-2):89-101. PubMed ID: 7687253 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). Kumar V; Stellrecht K; Sercarz E J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851 [TBL] [Abstract][Full Text] [Related]
12. Immunoregulation of encephalitogenic MBP-NAc1-11-reactive T cells by CD4+ TCR-specific T cells involves IL-4, IL-10 and IFN-gamma. Adlard K; Tsaknardis L; Beam A; Bebo BF; Vandenbark AA; Offner H Autoimmunity; 1999; 31(4):237-48. PubMed ID: 10789989 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99. Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700 [TBL] [Abstract][Full Text] [Related]
14. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II. Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816 [TBL] [Abstract][Full Text] [Related]
15. CD4 T suppressor cells mediate interferon tau protection against experimental allergic encephalomyelitis. Mujtaba MG; Soos JM; Johnson HM J Neuroimmunol; 1997 May; 75(1-2):35-42. PubMed ID: 9143235 [TBL] [Abstract][Full Text] [Related]
16. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody. Mannie MD; Morrison-Plummer J; McConnell TJ J Immunol; 1993 Dec; 151(12):7293-306. PubMed ID: 7505025 [TBL] [Abstract][Full Text] [Related]
18. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain. Skundric DS; Huston K; Shaw M; Tse HY; Raine CS Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038 [TBL] [Abstract][Full Text] [Related]
19. Experimental allergic encephalomyelitis in susceptible and resistant strains of mice after adoptive transfer of T cells activated by antibodies to the T cell receptor complex. Zhao ML; Xia JQ; Fritz RB J Neuroimmunol; 1992 Sep; 40(1):31-9. PubMed ID: 1381381 [TBL] [Abstract][Full Text] [Related]
20. CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis. Grewal IS; Foellmer HG; Grewal KD; Wang H; Lee WP; Tumas D; Janeway CA; Flavell RA Immunity; 2001 Mar; 14(3):291-302. PubMed ID: 11290338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]